BackIsracann Biosciences Overview

Isracann Biosciences Other Current Liabilities

Isracann Biosciences's other current liabilities is $630K.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$629899.00
↑ 33.42% YoYΔ $157796.00 vs prior year quarter

Peer trimmed avg / median

Loading

Isracann Biosciences Other Current Liabilities History

Loading

Isracann Biosciences vs. peers: Other Current Liabilities Comparison

Loading

Isracann Biosciences Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Isracann Biosciences (IPOT.CN) FAQ

Isracann Biosciences posts a other current liabilities of $630K as of August 2022. That compares with $470K in the prior-year period — up 33.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Isracann Biosciences's other current liabilities was $470K. The latest reading is $630K — a 33.4% year-over-year increase (period ending August 2022). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Isracann Biosciences's financial statement story. At $630K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for IPOT.CN's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Isracann Biosciences's other metric pages and overview cover the third.